0000950170-23-071472.txt : 20231219
0000950170-23-071472.hdr.sgml : 20231219
20231219160529
ACCESSION NUMBER: 0000950170-23-071472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231216
FILED AS OF DATE: 20231219
DATE AS OF CHANGE: 20231219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Imran Talat
CENTRAL INDEX KEY: 0001869579
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40672
FILM NUMBER: 231497293
MAIL ADDRESS:
STREET 1: C/O RANI THERAPEUTICS HOLDINGS, INC.
STREET 2: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001856725
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
BUSINESS PHONE: (408) 457-3700
MAIL ADDRESS:
STREET 1: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
4
1
ownership.xml
4
X0508
4
2023-12-16
0001856725
Rani Therapeutics Holdings, Inc.
RANI
0001869579
Imran Talat
2051 RINGWOOD AVE
SAN JOSE
CA
95131
true
true
false
false
Chief Executive Officer
false
Stock Option (Right to Buy)
5.44
2023-12-16
4
D
false
479667
D
2033-03-26
Class A Common Stock
479667
95933
D
Stock Option (Right to Buy)
2.84
2023-12-16
4
A
false
479667
A
2033-03-26
Class A Common Stock
479667
479667
D
Stock Option (Right to Buy)
13.21
2023-12-16
4
D
false
153650
D
2032-03-21
Class A Common Stock
153650
109750
D
Stock Option (Right to Buy)
2.84
2023-12-16
4
A
false
153650
A
2032-03-21
Class A Common Stock
153650
153650
D
Stock Option (Right to Buy)
19.56
2023-12-16
4
D
false
271875
D
2031-09-08
Class A Common Stock
271875
453125
D
271875
2.84
2023-12-16
4
A
false
271875
A
2031-09-08
Class A Common Stock
271875
271875
D
Stock Option (Right to Buy)
9.44
2023-12-16
4
D
false
31252
D
2031-07-28
Class A Common Stock
31252
47699
D
Stock Option (Right to Buy)
2.84
2023-12-16
4
A
false
31252
A
2031-07-28
Class A Common Stock
31252
31252
D
The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.
The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.
The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to
the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's
Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.
The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022.
The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 14, 2022; and 1/48th of the shares subject to the option vest monthly over the remaining three years.
The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021.
Talat Imran
2023-12-19